ArticleFrontiers in oncology2026

Liposomal mitoxantrone, venetoclax and azacitidine in relapsed/refractory acute myeloid leukaemia and early induction failure: a single-centre real-world study.

Jiaxin Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.